Aristotle Capital Boston LLC Reduces Stake in Acadia Healthcare Company, Inc. $ACHC

Aristotle Capital Boston LLC decreased its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 9.3% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 601,654 shares of the company’s stock after selling 61,999 shares during the period. Aristotle Capital Boston LLC’s holdings in Acadia Healthcare were worth $8,537,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the stock. Boothbay Fund Management LLC lifted its holdings in Acadia Healthcare by 61.6% during the 4th quarter. Boothbay Fund Management LLC now owns 71,154 shares of the company’s stock worth $1,010,000 after purchasing an additional 27,134 shares in the last quarter. Guggenheim Capital LLC increased its stake in Acadia Healthcare by 191.2% in the 4th quarter. Guggenheim Capital LLC now owns 63,693 shares of the company’s stock worth $904,000 after acquiring an additional 41,824 shares during the last quarter. Schonfeld Strategic Advisors LLC increased its stake in Acadia Healthcare by 78.7% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 103,471 shares of the company’s stock worth $1,468,000 after acquiring an additional 45,572 shares during the last quarter. AQR Capital Management LLC increased its stake in Acadia Healthcare by 72.8% in the 4th quarter. AQR Capital Management LLC now owns 272,670 shares of the company’s stock worth $3,869,000 after acquiring an additional 114,868 shares during the last quarter. Finally, Jain Global LLC bought a new position in Acadia Healthcare in the 4th quarter worth about $1,862,000.

Analyst Ratings Changes

ACHC has been the topic of a number of research analyst reports. Raymond James Financial upgraded Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 target price on the stock in a research note on Monday, May 4th. TD Cowen upped their target price on Acadia Healthcare from $24.00 to $30.00 and gave the stock a “buy” rating in a research note on Tuesday, April 28th. Leerink Partners upped their target price on Acadia Healthcare from $14.00 to $22.00 and gave the stock a “market perform” rating in a research note on Thursday, February 26th. Jefferies Financial Group upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and upped their target price for the stock from $24.50 to $30.00 in a research note on Wednesday, June 3rd. Finally, Zacks Research upgraded Acadia Healthcare from a “strong sell” rating to a “hold” rating in a research note on Thursday, March 5th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $26.85.

Acadia Healthcare Price Performance

Shares of Acadia Healthcare stock opened at $23.50 on Thursday. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. The firm has a market capitalization of $2.16 billion, a PE ratio of -1.92, a price-to-earnings-growth ratio of 8.34 and a beta of 0.69. The business’s 50-day moving average price is $25.53 and its 200-day moving average price is $20.23. Acadia Healthcare Company, Inc. has a 12 month low of $11.43 and a 12 month high of $30.20.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.28 by $0.09. The firm had revenue of $828.80 million for the quarter, compared to analyst estimates of $823.51 million. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The company’s revenue was up 7.6% on a year-over-year basis. During the same period in the prior year, the company earned $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Sell-side analysts forecast that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.